Friday, July 10, 2026

pharma · Steroid refractory Acute Graft versus host Disease · moderate to severe atopic dermatitis

Medac Gesellschaft fuer

News and analysis for Medac Gesellschaft fuer on NovaPharmaNews — regulatory, clinical, and market coverage.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
3
Drugs
14
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Medac Gesellschaft fuer — regulatory, clinical, and market coverage.

News and analysis for Medac Gesellschaft fuer on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Medac Gesellschaft fuer yet.

Back to company overview →